Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
27 April, 2018 04:09 IST
Divis Lab receives import alert for Visakhapatnam facility
Source: IRIS | 21 Mar, 2017, 10.10AM
Comments  |  Post Comment

Divis Laboratories, a pharmaceutical ingredients and intermediates company, has received an Import Alert 66-40 from US Food and Drug Administration (USFDA) for its products manufactured at the company's Unit-II located at Visakhapatnam, Andhra Pradesh on March 20, 2017.

The agency has exempted the following products from the Import Alert-Levetiracetam, Gabapentin, Lamotrigine, Capecitabine, Naproxen sodium, Raltegravir potassium, Atovaquone, Chloropurine, BOC core succinate, 2, 4-wing active ester.

The company along with third party consultants is currently working to address the concerns of the USFDA and is making all efforts to fully meet the compliance requirements. 

Shares of the company declined Rs 138.7, or 17.54%, to trade at Rs 652.00. The total volume of shares traded was 1,228,420 at the BSE (10.02 a.m., Tuesday).



Divis Laboratories Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Thermax wins Rs 2.79 bn order for captive cogeneration plant - 26-Apr-2018 16:52
Yes Bank Q4 net jumps 29% to Rs 11.79 bn - 26-Apr-2018 15:25
Supreme Industries quarterly net up 32% - 26-Apr-2018 13:48
Infratel-Indus merger reflects India telco cash pressure: Fitch - 26-Apr-2018 13:44
Infratel-Indus merger reflects India telco cash pressure: Fitch - 26-Apr-2018 13:44
Indiabulls Real Estate quarterly profit zooms 23.69 times - 26-Apr-2018 12:49
Indoco gets UK health regulators nod to supply critical products - 26-Apr-2018 10:05
Zydus receives final approval from USFDA to market 2 drugs - 26-Apr-2018 09:36
Wipro Q4 earnings fall 6.7% q-o-q to Rs 18 bn - 25-Apr-2018 16:23
Sterlite Technologies quarterly profit surges 77% - 25-Apr-2018 15:42
Reliance Nippon Life Asset Management Q4 profit rises 35% to Rs 1.62 bn - 25-Apr-2018 15:34
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer